Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia | MicrobiomeTrials← Back to trialsNCT04886284
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-05-20Est. Completion: 2027-04
Enrollment target: 60 participants Locations- Foothills Medical Centre, Calgary, Alberta, Canada
- Hamilton Health Sciences (Hamilton General Hospital and Juravinski Hospital), Hamilton, Ontario, Canada
- Niagara Health - St. Catharines site, Saint Catharines, Ontario, Canada
- Hospital de la Cité de la Sante, Laval, Quebec, Canada
- Jewish General Hospital, Montreal, Quebec, Canada
- McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal, Quebec, Canada
Other microbiome trials you might be interested in
Staphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus BacteremiaS. Aureus Bloodstream InfectionStaphylococcus Aureus Endocarditis
This is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream i…
Concord, AustraliaEst. completion Jan 2027
Staph Aureus Bacteremia
Staphylococcus aureus bacteremia (SAB) is associated with high morbidity and mortality rates with an incidence dispropor…
Athabasca, CanadaCompleted Oct 31, 2025